Skip to main content

datastreet.in

Goldline Pharmaceutical share price locked in 5% lower circuit after bumper debut

Goldline Pharmaceutical shares debuted strongly on BSE SME, opening at ₹59.75, 40% above the issue price of ₹43. The IPO, which closes on May 14, saw a subscription status of 600.53x by day 3.

Source :- mint – markets Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *